Reuters logo
4 个月前
BRIEF-Astrazeneca signs deal with Circassia over Almirall's products
2017年3月17日 / 早上7点43分 / 4 个月前

BRIEF-Astrazeneca signs deal with Circassia over Almirall's products

1 分钟阅读

March 17 (Reuters) - Almirall SA:

* Astrazeneca enters into a strategic collaboration with Circassia for the development and commercialization of Tudorza and Duaklir in the United States

* Says Tudorza, Duaklir are products licensed by Almirall to Astrazeneca in an agreement from July 30, 2014

* Under terms of collaboration, Circassia will lead promotion of Tudorza in the US and has been granted an option to gain full commercial rights in the future Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below